alphaveORTINGLOBE₹16.30

ORTIN GLOBAL LIMITED

Annual Quarterly₹ CrorePeersLASA MANGALAM BIOFILCHEM VINEETLAB KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹13.3 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	2.1	0.3	0.1	0.1
Other Income	0.2	0.0	0.3	0.3
Total Income	2.3	0.4	0.4	0.4
Expenses
+ Cost of Materials Consumed	2.3	0.2	0.1	0.1
+ Changes in Inventories	1.4	0.0	0.0	0.0
+ Employee Benefit Expense	0.6	0.2	0.2	0.2
+ Finance Costs	0.5	0.0	0.0	0.0
+ Depreciation & Amortisation	0.2	0.0	0.0	0.0
+ Other Expenses	4.4	0.9	0.9	1.0
Total Expenses	9.4	1.2	1.1	1.2
EBITDA	-6.5	-0.9	-1.0	-1.2
EBIT	-6.8	-0.9	-1.0	-1.2
Profit
PBT before Exceptional Items	-7.1	-0.9	-0.7	-0.9
+ Exceptional Items	-0.0	0.0	0.0	0.0
Pretax Income	-7.1	-0.8	-0.7	-0.9
+ Current Tax	1.3	0.0	0.0	0.0
+ Deferred Tax	-0.3	0.0	0.0	0.0
Tax Expense	1.0	0.0	0.0	0.0
Net Income	-8.0	-0.8	-0.7	-0.9
+ Net Income — Continuing Ops	-8.0	-0.8	-0.7	-0.9
Total Comprehensive Income	-8.0	-0.8	-0.7	-0.9
Per Share
Basic EPS	-9.89	-1.04	-0.91	-1.12
Diluted EPS	-9.89	-1.04	-0.91	-1.12
Per Share — as-filed variants
Basic EPS — Continuing Operations	-9.89	-1.04	-0.91	-1.12
Diluted EPS — Continuing Operations	-9.89	-1.04	-0.91	-1.12
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	-1.6	0.1	0.0	0.0
Gross Margin %	-75.95	37.29	3.98	16.60
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-7.1	-0.9	-0.7	-0.9
− Exceptional Items (reconciliation)	-0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	-8.0	-0.9	-0.7	-0.9
EPS Adj	-9.89	-1.06	-0.91	-1.12
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00
Paid Up Equity Capital	8.1	8.1	8.1	8.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.